I saw this post this afternoon on the PharmaGossip blog reporting on a story in The Boston Globe. It seems the rumored takeover of Genzyme by Sanofi-Aventis is making many of the Genzyme patients with Pompe's, Gaucher's and Fabry's disease nervous.
The article goes on to interview patients who explain how Genzyme has cultivated a personal relationship with them and their families over the past 15 years and how they are fearful that Sanofi would NOT be able to sustain this in an acquisition.
The article does bring to light the human side of a merger from the patient's point of view -- something not generally talked about in the financial press certainly. It also shows another side to Genzyme CEO Henri Termeer - detailing his personal contact/relationship with some patients. This might be seen in marked contrast again to notes about Termeer in the business press this past year - plus even in this blog from time to time.
This is a good article to read for another perspective.
Posted by Bruce Lehr August 8th 2010.